<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02743234</url>
  </required_header>
  <id_info>
    <org_study_id>FACIT</org_study_id>
    <nct_id>NCT02743234</nct_id>
  </id_info>
  <brief_title>Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection</brief_title>
  <acronym>FACIT</acronym>
  <official_title>Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized open label clinical trial to compare the clinical and microbiological efficacy of
      fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium
      difficile infection
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiological response</measure>
    <time_frame>8 weeks</time_frame>
    <description>Negative Clostridium difficile test 8 weeks after finishing allocated treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiological response week 1</measure>
    <time_frame>1 week</time_frame>
    <description>Negative Clostridium difficile test one week after finishing treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical response week 8</measure>
    <time_frame>8 weeks</time_frame>
    <description>Absence of abdominal pain and less than 3 bowel movements per day and a stool consistency of Bristol 5 or lower, corresponding to absence of diarrhea, 8 weeks after finishing allocated treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological response week 26</measure>
    <time_frame>26 weeks</time_frame>
    <description>Negative Clostridium difficile test 26 weeks after finishing treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical response week 26</measure>
    <time_frame>26 weeks</time_frame>
    <description>Absence of abdominal pain and less than 3 bowel movements per day and a stool consistency of Bristol 5 or lower, corresponding to absence of diarrhea, 26 weeks after finishing allocated treatment</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Clostridium Difficile Infection</condition>
  <arm_group>
    <arm_group_label>FMT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fecal microbiota transplantation (FMT) following 4-10 days of vancomycin 125 mg x 4, using cryopreserved feces from a healthy anonymous donor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fidaxomicin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 days fidaxomicin 200 mg x 2 daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vancomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 days vancomycin 125 x 4 daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fecal microbiota transplantation</intervention_name>
    <description>FMT follows 4-10 days of vancomycin 125 mg x 4 daily</description>
    <arm_group_label>FMT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fidaxomicin</intervention_name>
    <description>Fidaxomicin 200 mg x 2 daily for 10 days</description>
    <arm_group_label>Fidaxomicin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>Vancomycin 125 mg x 4 daily for 10 days</description>
    <arm_group_label>Vancomycin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Relapse of Clostridium difficile infection with previous trial of vancomycin or
        fidaxomicin

        Exclusion Criteria:

          1. Pregnancy or breastfeeding

          2. Does not speak or understand the Danish language

          3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin

          4. fulminant colitis which contraindicates medical treatment

          5. physician's evaluation that the patient cannot tolerate project inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens F Dahlerup, MD DrMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian L Hvas, MD PhD</last_name>
    <email>chrishva@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian L Hvas, MD PhD</last_name>
      <email>chrishva@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jens F Dahlerup, MD DrMSc</last_name>
      <email>jensdahl@rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2016</study_first_posted>
  <last_update_submitted>November 20, 2016</last_update_submitted>
  <last_update_submitted_qc>November 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

